0001209191-22-042864.txt : 20220721 0001209191-22-042864.hdr.sgml : 20220721 20220721164136 ACCESSION NUMBER: 0001209191-22-042864 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220720 FILED AS OF DATE: 20220721 DATE AS OF CHANGE: 20220721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TSANG Benson Kwan Hung CENTRAL INDEX KEY: 0001745135 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38112 FILM NUMBER: 221097518 MAIL ADDRESS: STREET 1: C/O ATHENEX, INC. STREET 2: 1001 MAIN STREET, SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Athenex, Inc. CENTRAL INDEX KEY: 0001300699 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 431985966 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 BUSINESS PHONE: 716-898-8625 MAIL ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20131223 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC DATE OF NAME CHANGE: 20040817 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-07-20 0 0001300699 Athenex, Inc. ATNX 0001745135 TSANG Benson Kwan Hung C/O ATHENEX, INC. 1001 MAIN STREET, SUITE 600 BUFFALO NY 14203 1 0 0 0 Common Stock 2022-07-20 4 A 0 17280 0.6655 A 42572 D Stock Option (Right to Buy) 19.51 2022-07-02 2028-07-02 Common Stock 9750 9750 D Stock Option (Right to Buy) 13.17 2029-02-28 Common Stock 17500 17500 D Stock Option (Right to Buy) 12.45 2030-06-05 Common Stock 20000 20000 D Stock Option (Right to Buy) 3.80 2031-08-03 Common Stock 10000 10000 D Restricted Stock Units Common Stock 10000 10000 D Stock Option (Right to Buy) 0.457 2032-06-28 Common Stock 20000 20000 D Shares purchased from the Issuer under a Salary Deduction and Stock Purchase Agreement at the Nasdaq Official Closing Price on the date of purchase. This option vests in four equal annual installments beginning on February 28, 2020. This option vests in four equal annual installments beginning on June 5, 2021. This option vests on August 3, 2022. Each restricted stock unit represents a contingent right to receive one share of stock. The restricted stock units vest on August 3, 2022. This option vests on June 28, 2023. /s/ Staci Holquist, Attorney-in-Fact 2022-07-21